Blueprint Medicines Corp (BPMC) Insider Trading
- $348,278.00
- $152,874,979.57
- March 28, 2024
- Jeffrey W Albers
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 6, 2016 | CEO | 17,000 | $20.42 | Sell | $347,140.00 | |
| Dec. 17, 2015 | insider | 31,119 | $25.05 | Sell | $779,530.95 | |
| Nov. 27, 2015 | Insider | 287,415 | $21.48 | Sell | $6,173,674.20 | |
| Nov. 24, 2015 | Insider | 161,271 | $20.14 | Sell | $3,247,997.94 | |
| Nov. 23, 2015 | Insider | 189,572 | $20.15 | Sell | $3,819,875.80 | |
| Nov. 19, 2015 | Insider | 237,218 | $19.76 | Sell | $4,687,427.68 | |
| Nov. 17, 2015 | Insider | 27,490 | $20.60 | Sell | $566,294.00 | |
| Nov. 3, 2015 | insider | 84,998 | $21.05 | Sell | $1,789,207.90 |
Insiders are both buying and selling Blueprint Medicines Corp stock.
The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Daniel Lynch, Christopher K Murray, Marion Dorsch, George Demetri, Nicholas Lydon, Anthony L Boral, Tracey L Mccain, Fmr Llc, L. Becker Hewes, Christina Rossi, Christoph Lengauer, Michael Landsittel, Mark Alan Goldberg, Fouad Namouni, Debra Durso-Bumpus, Charles A Rowland Jr, Percy H Carter, Kevin P. Starr, Rock Ventures Ii L.P. Third, Lonnel Coats, Alexis Borisy, and Mark J Levin
The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 38 trades.
Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.
Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.
The most recent insider trade for Blueprint Medicines Corp was on March 28, 2024.
The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.
The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.